{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:19:00Z","timestamp":1767925140252,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS106305"],"award-info":[{"award-number":["NS106305"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s12035-023-03711-2","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T07:02:08Z","timestamp":1697871728000},"page":"2165-2175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CMS121 Partially Attenuates Disease Progression in Mouse Models of Huntington\u2019s Disease"],"prefix":"10.1007","volume":"61","author":[{"given":"Gamze","family":"Ates","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0694-0610","authenticated-orcid":false,"given":"Pamela","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,21]]},"reference":[{"key":"3711_CR1","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","volume":"63","author":"M Borrell-Pages","year":"2006","unstructured":"Borrell-Pages M, Zala D, Humbert S, Saudou F (2006) Huntington\u2019s Disease: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63:2642\u20132660","journal-title":"Cell Mol Life Sci"},{"key":"3711_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3727\/000000007783464687","volume":"16","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, Shannon KM, Kordower JH (2007) Huntington\u2019s Disease: pathological mechanisms and therapeutic strategies. Cel Transpl 16:301\u2013312","journal-title":"Cel Transpl"},{"key":"3711_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20071619","volume":"412","author":"S Imarisio","year":"2008","unstructured":"Imarisio S, Carmichael J, Korolchuk V, Chen C-W, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, Rubinsztein DC (2008) Huntington\u2019s Disease: from pathology and genetics to potential therapeutics. Biochem J 412:191\u2013209","journal-title":"Biochem J"},{"key":"3711_CR4","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington\u2019s Disease. Eur J Neurosci 27:2803\u20132820","journal-title":"Eur J Neurosci"},{"key":"3711_CR5","first-page":"1","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA, Scahill RI, Wetzel R et al (2015) Huntington Disease. Nat Rev Disease Primers 1:1\u201321","journal-title":"Nat Rev Disease Primers"},{"key":"3711_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12041-018-0957-1","volume":"97","author":"M Panday","year":"2018","unstructured":"Panday M, Rajamma U (2018) Huntington\u2019s Disease: the coming of age. J Genet 97:649\u2013664","journal-title":"J Genet"},{"key":"3711_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ, Flower MD, Ross CA, Wild EJ (2020) Huntington Disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 16:529\u2013546","journal-title":"Nat Rev Neurol"},{"key":"3711_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnmol.2019.00068","volume":"12","author":"BD Paul","year":"2019","unstructured":"Paul BD, Snyder SH (2019) Impaired redox signaling in Huntington\u2019s Disease: therapeutic implications. Front Mol Neurosci 12:68","journal-title":"Front Mol Neurosci"},{"key":"3711_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3233\/JHD-200395","volume":"9","author":"E Machiela","year":"2020","unstructured":"Machiela E, Southwell AL (2020) Biological aging and the cellular pathogenesis of Huntington\u2019s Disease. J Huntington\u2019s Dis 9:115\u2013128","journal-title":"J Huntington\u2019s Dis"},{"key":"3711_CR10","doi-asserted-by":"crossref","unstructured":"Rocha NP, Ribeiro FM, Furr-Stimming E, Teixeira AL (2016): Neuroimmunology of Huntington\u2019s disease: Revisiting evidence from human studies. Med Inflamm 2016:8653132","DOI":"10.1155\/2016\/8653132"},{"key":"3711_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2741\/s425","volume":"7","author":"P Maher","year":"2015","unstructured":"Maher P (2015) How fisetin reduces the impact of age and Disease on CNS function. Front Biosci 7:58\u201382","journal-title":"Front Biosci"},{"key":"3711_CR12","doi-asserted-by":"crossref","unstructured":"Maher P (2020): Preventing and treating neurological disorders with the flavonol fisetin. Brain Plast","DOI":"10.3233\/BPL-200104"},{"key":"3711_CR13","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.chembiol.2020.10.010","volume":"27","author":"P Maher","year":"2020","unstructured":"Maher P, Currais A, Schubert D (2020) Using the oxytosis\/ferroptosis pathway to understand and treat age-associated neurodegenerative Diseases. Cell Chem Biol 27:1456\u20131471","journal-title":"Cell Chem Biol"},{"key":"3711_CR14","first-page":"1","volume":"2020","author":"CI Wasser","year":"2020","unstructured":"Wasser CI, Mercieca E-C, Kong G, Hannan AJ, McKeown SJ, Glikmannn-Johnston Y, Stout JC (2020) Gut dysbiosis in Huntington\u2019s Disease: associations among gut microbiota, cognitive performance and clinical outcomes. Brain Commun 2020:1\u201313","journal-title":"Brain Commun"},{"key":"3711_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/hmg\/ddq460","volume":"20","author":"P Maher","year":"2011","unstructured":"Maher P, Dargusch R, Bodai L, Gerard P, Purcell JM, Marsh JL (2011) ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington\u2019s Disease. Hum Mol Gen 20:261\u2013270","journal-title":"Hum Mol Gen"},{"key":"3711_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1021\/jm2012563","volume":"55","author":"C Chiruta","year":"2012","unstructured":"Chiruta C, Schubert D, Dargusch R, Maher P (2012) Chemical modification of the multi-target neuroprotective compound fisetin. J Med Chem 55:378\u2013389","journal-title":"J Med Chem"},{"key":"3711_CR17","doi-asserted-by":"publisher","first-page":"101648","DOI":"10.1016\/j.redox.2020.101648","volume":"36","author":"G Ates","year":"2020","unstructured":"Ates G, Goldberg J, Currais A, Maher P (2020) CMS121, a fatty acid synthase inhibitor, protects against excess lipi peroxidation and inflammation and alleviates cognitive loss in a transgenic model of Alzheimer\u2019s Disease. Redox Biol 36:101648","journal-title":"Redox Biol"},{"key":"3711_CR18","doi-asserted-by":"publisher","first-page":"e47866","DOI":"10.7554\/eLife.47866","volume":"8","author":"A Currais","year":"2019","unstructured":"Currais A, Huang L, Goldberg J, Petrascheck M, Ates G, Pinto-Duarte A, Shokhirev M, Schubert D, Maher P (2019) Elevating acetyl-CoA levels reduces aspects of brain aging. eLife 8:e47866","journal-title":"eLife"},{"key":"3711_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/acel.12185","volume":"13","author":"A Currais","year":"2014","unstructured":"Currais A, Prior M, Dargusch R, Armando A, Ehren J, Schubert D, Quehenberger O, Maher P (2014) Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer\u2019s Disease transgenic mice. Aging Cell 13:379\u2013390","journal-title":"Aging Cell"},{"key":"3711_CR20","first-page":"299","volume":"73","author":"A Currais","year":"2018","unstructured":"Currais A, Farrokhi C, Dargusch R, Armando A, Quehenberger O, Schubert D, Maher P (2018) Fisetin reduces the impact of aging on behavior and physiology in the rapidly aging SAMP8 mouse. J Gerentol A Biol Sci Med Sci 73:299\u2013307","journal-title":"J Gerentol A Biol Sci Med Sci"},{"key":"3711_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1152\/jn.00762.2011","volume":"107","author":"DM Cummings","year":"2012","unstructured":"Cummings DM, Alaghband Y, Hickey MA, Joshi PR, Hong SC, Zhu C, Ando TK, Andre VM, Cepeda C, Watson JB, Levine MS (2012) A critical window of CAG repeat-length correlates with phenotype severity in the R6\/2 mouse model of Huntington\u2019s Disease. J Neurophysiol 107:677\u2013691","journal-title":"J Neurophysiol"},{"key":"3711_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","volume":"35","author":"L Menalled","year":"2009","unstructured":"Menalled L, El-Khodor BF, Patry M, Suarez-Farinas M, Orenstein SJ, Zahasky B, Leahy C, Wheeler V, Yang XW, MacDonald M et al (2009) Systematic behavioral evaluation of Huntington\u2019s Disease transgenic and knock-in mouse models. Neurobiol Dis 35:319\u2013336","journal-title":"Neurobiol Dis"},{"key":"3711_CR23","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang Y-Z et al (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington\u2019s Disease. Hum Mol Gen 12:1555\u20131567","journal-title":"Hum Mol Gen"},{"key":"3711_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321","journal-title":"Bioinformatics"},{"key":"3711_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2012","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2012) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321","journal-title":"Bioinformatics"},{"key":"3711_CR26","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK (2012) Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res 40:4288\u20134297","journal-title":"Nucleic Acids Res"},{"key":"3711_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE (2002) Gene expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207\u2013210","journal-title":"Nucleic Acids Res"},{"key":"3711_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12920-020-00822-w","volume":"13","author":"J Cheng","year":"2020","unstructured":"Cheng J, Liu H-P, Lin W-Y, Tsai F-J (2020) Identification of contributing genes of Huntington\u2019s Disease by machine learning. BMC Med Genomics 13:176","journal-title":"BMC Med Genomics"},{"key":"3711_CR29","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1212\/WNL.0000000000005321","volume":"90","author":"EB Johnson","year":"2018","unstructured":"Johnson EB, Byrne LM, Gregory S, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RA, Zetterberg H, Tabrizi SJ et al (2018) Neurofilament light protein in blood predicts regional atrophy in Huntington Disease. Neurol 90:e717\u2013e723","journal-title":"Neurol"},{"key":"3711_CR30","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.3390\/ijms22116111","volume":"22","author":"G Limoni","year":"2021","unstructured":"Limoni G (2021) Modelling and refining neuronal circuits with guidance cues: involvement of semaphorins. Int J Mol Sci 22:6111","journal-title":"Int J Mol Sci"},{"key":"3711_CR31","doi-asserted-by":"publisher","first-page":"E11293","DOI":"10.1073\/pnas.1711243115","volume":"114","author":"RR Handley","year":"2017","unstructured":"Handley RR, Reid SJ, Brauning R, Maclean P, Mears ER, Fourie I, Patassini S, Cooper GJS, Rudiger SR, McLaughlan CJ et al (2017) Brain urea increase in an early Huntington\u2019s Disease pathogenic event observed in a prodromal transgenic sheep model and HD cases. Proc Natl Acad Sci U S A 114:E11293\u2013E11302","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3711_CR32","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/febs.14379","volume":"285","author":"AT Dinkova-Kostova","year":"2018","unstructured":"Dinkova-Kostova AT, Kostov RV, Kazantsev AG (2018) The role of Nrf2 signaling in counteracting neurodegenerative Diseases. FEBS J 285:3576\u20133590","journal-title":"FEBS J"},{"key":"3711_CR33","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.3390\/ijms22179592","volume":"22","author":"E Zgorzynska","year":"2021","unstructured":"Zgorzynska E, Dziedzic B, Walczewska A (2021) An overview of the Nrf2\/ARE pathway and its role in neurodegenerative Diseases. Int J Mol Sci 22:9592","journal-title":"Int J Mol Sci"},{"key":"3711_CR34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.18632\/aging.101202","volume":"9","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Doornebal EJ, Pirtskhalava T, Giorgadze N, Wentworth M, Fuhrmann-Stroissnigg H, Niedernhofer LJ, Robbins PD, Tchkonia T, Kirkland JL (2017) New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging 9:955\u2013963","journal-title":"Aging"},{"key":"3711_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","volume":"36","author":"MJ Yousefzadeh","year":"2018","unstructured":"Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L, Fuhrmann-Stroissnigg H, Xu M, Ling YY, Melos KI, Pirtskhalava T, Inman CL et al (2018) Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36:18\u201328","journal-title":"EBioMedicine"},{"key":"3711_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12920-014-0060-2","volume":"7","author":"A Neueder","year":"2014","unstructured":"Neueder A, Bates GP (2014) A common gene expression signature in Huntington\u2019s Disease patient brain regions. BMC Med Genomics 7:60","journal-title":"BMC Med Genomics"},{"key":"3711_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/d41586-021-01177-7","volume":"593","author":"D Kwon","year":"2021","unstructured":"Kwon D (2021) Genetic therapies for Huntington\u2019s Disease fail in clinical trials. Nature 593:180","journal-title":"Nature"},{"key":"3711_CR38","doi-asserted-by":"publisher","first-page":"785703","DOI":"10.3389\/fncel.2021.785703","volume":"15","author":"H Komatsu","year":"2021","unstructured":"Komatsu H (2021) Innovative therapeutic approaches for Huntington\u2019s Disease: from nucleic acids to GPCR-targeting small molecules. Front Cell Neurosci 15:785703","journal-title":"Front Cell Neurosci"},{"key":"3711_CR39","doi-asserted-by":"publisher","first-page":"105642","DOI":"10.1016\/j.bioorg.2022.105642","volume":"120","author":"SJ Devadiga","year":"2022","unstructured":"Devadiga SJ, Bharate SS (2022) Recent developments in the management of Huntinton\u2019s Disease. Bioorg Chem 120:105642","journal-title":"Bioorg Chem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03711-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03711-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03711-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T08:37:38Z","timestamp":1711528658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03711-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,21]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3711"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03711-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,21]]},"assertion":[{"value":"22 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All of the mouse studies were performed in accordance with the recommendations in the US Public Health Service Guide for the Care and Use of Laboratory Animals. The protocol was approved by the Animal Care and Use Committee of the Salk Institute for Biological Studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}